IP Library Assignment 035603/0731
Patent Assignment
Reel/Frame 035603/0731

Assignment of Assignor's Interest

Recorded: 2015-05-06 Pages: 11
Assignor
GRADALIS, INC.
Executed: 2014-02-28
Assignee
STRIKE BIO, INC.
2330 INWOOD ROAD, SUITE 110, DALLAS, TEXAS, 75235
Covered Properties (57)
Highly Pure Plasmid Dna Preparations and Processes for Preparing the Same
Targeted Delivery Using Tissue-Specific Peptidomimetic Ligands
Novel Therapeutic Rna Interference Technology Targeted to the Pdx-1 Oncogene in Pdx-1 Expressing Neuroendocrine Tumors
Compositions and Methods for Treating Prostate Cancer
Antagonists of Mir-196A
Methods and Compositions to Treat Cancer Using Bifunctional Src-3 Shrna
Ewing's Sarcoma Bifunctional Shrna Design
Bi-Functional Short-Hairpin Rna (Bi-Shrna) Specific for Single-Nucleotide Kras Mutations
Reversible Masking of Liposomal Complexes for Targeted Delivery
Patent: 7,037,520 →
Application: 10/393,101 →
Publication: US 2003/0180950
Novel Shrna Molecules and Methods of Use Thereof
Patent: 8,252,526 →
Application: 11/983,482 →
Publication: US 2008/0269474
Dipeptide Mimics, Libraries Combining Two Dipeptide Mimics with a Third Group, and Methods for Production Thereof
Application: 12/181,168 →
Publication: US 2009/0264315
Highly Pure Plasmid Dna Preparations
Application: 12/433,645 →
Publication: US 2011/0020924
Processes for the Preparation of Highly Pure Plasmid Compositions by Enzymatic Digestion of Colanic Acid
Patent: 8,969,068 →
Application: 12/433,674 →
Publication: US 2009/0275088
Polypeptides Having Colanic Acid-Degrading Activity
Patent: 8,460,908 →
Application: 12/433,691 →
Publication: US 2009/0275122
Processes for the Digestion of Colanic Acid
Patent: 8,647,857 →
Application: 12/433,701 →
Publication: US 2010/0075404
Methods and Compositions for Modulating Sialic Acid Production and Treating Hereditary Inclusion Body Myopathy
Patent: 9,273,300 →
Application: 12/526,239 →
Publication: US 2011/0027373
Targeted Delivery Using Tissue-Specific Peptidomimetic Ligands
Patent: 8,333,988 →
Application: 12/875,723 →
Publication: US 2011/0059161
Histone Octamers for Increased Nucleic Acid Transfer
Application: 12/887,666 →
Publication: US 2011/0081403
Novel Therapeutic Rna Interference Technology Targeted to the Pdx-1 Oncogene in Pdx-1 Expressing Neuroendocrine Tumors
Patent: 8,361,983 →
Application: 12/913,515 →
Publication: US 2011/0117183
CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)
Application: 13/111,677 →
Publication: US 2011/0286979
Design and Construction of Bifunctional Short Hairpin Rna
Patent: 8,758,998 →
Application: 13/364,053 →
Publication: US 2012/0183955
Bi-Functional Shrna Targeting Stathmin 1 and Uses Thereof
Patent: 8,906,874 →
Application: 13/410,130 →
Publication: US 2012/0251617
Dipeptide Mimics, Libraries Combining Two Dipeptide Mimics with a Third Group, and Methods for Production Thereof
Patent: 9,562,023 →
Application: 13/418,917 →
Publication: US 2012/0232268
Highly Pure Plasmid DNA Preparations
Application: 13/431,359 →
Publication: US 2012/0231537
Novel Shrna Molecules and Methods of Use Thereof
Patent: 8,808,983 →
Application: 13/538,619 →
Publication: US 2013/0071928
Novel Shrna Molecules and Methods of Use Thereof
Patent: 8,735,058 →
Application: 13/538,853 →
Publication: US 2013/0078719
Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid to Increase Sialylation
Application: 13/605,946 →
Publication: US 2013/0058998
Compositions and Methods for Treating Prostate Cancer
Application: 13/607,546 →
Publication: US 2013/0064881
Targeted Delivery Using Tissue-Specific Peptidomimetic Ligands
Patent: 9,181,225 →
Application: 13/664,288 →
Publication: US 2013/0129813
Novel Therapeutic RNA Interference Technology Targeted to the PDX-1 Oncogene in PDX-1 Expressing Neuroendocrine Tumors
Patent: 9,133,459 →
Application: 13/693,578 →
Publication: US 2013/0084331
Antagonists of Mir-196A
Application: 13/738,742 →
Publication: US 2013/0295160
METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNA
Application: 13/851,464 →
Publication: US 2013/0259925
BI-FUNCTIONAL shRNA TARGETING MESOTHELIN AND USES THEREOF
Application: 13/852,446 →
Publication: US 2013/0259926
Ewing's Sarcoma Bifunctional shRNA Design
Application: 13/855,109 →
Publication: US 2013/0259927
Polypeptides Having Colanic Acid-Degrading Activity
Patent: 8,524,475 →
Application: 13/858,697 →
Publication: US 2013/0210118
Bi-Functional Short-Hairpin RNA (Bi-shRNA) Specific for Single-Nucleotide KRAS Mutations
Patent: 9,353,373 →
Application: 13/890,957 →
Publication: US 2013/0302407
METHODS FOR TREATING TRIPLE NEGATIVE BREAST CANCER USING BIFUNCTIONAL SRC 3 shRNA
Application: 13/917,499 →
Publication: US 2013/0266639
Polypeptides Having Colanic Acid-Degrading Activity
Patent: 8,735,119 →
Application: 13/954,682 →
Publication: US 2013/0309752
Highly Pure Plasmid Dna Preparations
Application: 14/099,488 →
Publication: US 2014/0093888
Processes for the Digestion of Colanic Acid
Application: 14/103,573 →
Publication: US 2014/0349389
Methods and compositions for gene silencing by simultaneous activating multiple RNA interfering pathways
Application: 60/857,846 →
Methods and compositions for gene silencing by simultaneous activating multiple RNA interfering pathways
Application: 60/897,214 →
Gene therapy for IBM-2
Application: 60/900,034 →
Methods and compositions for gene silencing by simultaneous activating multiple RNA interfering pathways
Application: 60/932,653 →
Purification of plasmid DNA
Application: 61/125,916 →
Detection of plasmid DNA contaminants
Application: 61/125,923 →
Targeted Delivery Using Tissue-Specific Peptidomimetic Ligands
Application: 61/239,648 →
Histone Octamers for Increased Nucleic Acid Transfer
Application: 61/247,729 →
Novel Therapeutic Rna Interference Technology Targeted to the Pdx-1 Oncogene in Pdx-1 Expressing Neuroendocrine Tumors
Application: 61/256,867 →
CHEMOSENSITIZATION BY BI-FUNCTIONAL SMALL HAIRPIN RNA (bi-shRNA)
Application: 61/346,709 →
Encapsulated N-Acetylmannosamine or N-Acetylneuraminic Acid to Increase Sialylation
Application: 61/531,934 →
Compositions and Methods for Treating Prostate Cancer
Application: 61/532,403 →
Antagonists of MIR-196A
Application: 61/585,092 →
Bi-Functional shRNA Targeting Mesothelin and Uses Thereof
Application: 61/616,824 →
Methods and Compositions to Treat Cancer Using Bifunctional SRC 3 shRNA
Application: 61/616,873 →
Ewing's Sarcoma Bifunctional shRNA Design
Application: 61/619,077 →
Bi-Functional Short-Hairpin Rna (Bi-Shrna) Specific for Single-Nucleotide Kras Mutations
Application: 61/644,875 →
Related Assignments (23)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Mar 20, 2003
From: TEMPLETON, NANCY SMYTH
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 013893/0036 →
Assignment of Assignor's Interest Jul 16, 2008
From: RAO, DONALD
To: GRADALIS, INC.
Reel/Frame 021244/0444 →
Assignment of Assignor's Interest Jun 1, 2009
From: TEMPLETON, NANCY SMYTH
To: GRADALIS,INC.
Reel/Frame 022760/0578 →
Assignment of Assignor's Interest Jun 1, 2009
From: TEMPLETON, NANCY SMYTH
To: GRADALIS,INC.
Reel/Frame 022760/0502 →
Assignment of Assignor's Interest Jun 1, 2009
From: TEMPLETON, NANCY SMYTH
To: GRADALIS,INC.
Reel/Frame 022760/0421 →
Assignment of Assignor's Interest Jun 1, 2009
From: TEMPLETON, NANCY SMYTH
To: GRADALIS,INC.
Reel/Frame 022760/0649 →
Assignment of Assignor's Interest Jun 1, 2009
From: TEMPLETON, NANCY SMYTH
To: GRADALIS,INC.
Reel/Frame 022760/0342 →
Assignment of Assignor's Interest May 5, 2010
From: MAPLES, PHILLIP; JAY, CHRIS M.; NEMUNAITIS, JOHN
To: GRADALIS, INC.
Reel/Frame 024338/0555 →
Assignment of Assignor's Interest Sep 22, 2010
From: TEMPLETON, NANCY SMYTH
To: GRADALIS, INC.
Reel/Frame 025030/0685 →
Confirmatory License Oct 4, 2010
From: TEXAS A&M UNIVERSITY SYSTEM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 025082/0887 →
Assignment of Assignor's Interest Dec 15, 2010
From: NEMUNAITIS, JOHN; RAO, DONALD; BRUNICARDI, F. CHARLES
To: GRADALIS, INC.
Reel/Frame 025506/0253 →
Assignment of Assignor's Interest Dec 15, 2010
From: TEMPLETON, NANCY SMYTH
To: GRADALIS, INC.
Reel/Frame 025505/0958 →
Assignment of Assignor's Interest Aug 11, 2011
From: TONG, ALEX W.; YANG, YU; RAO, DONALD; MAPLES, PHILLIP B.
To: GRADALIS, INC.
Reel/Frame 026736/0253 →
Corrective Assignment to Correct Assignor's Name Previously Recorded on Reel 026736, Frame 0253. Nov 4, 2011
From: YU, YANG
To: GRADALIS, INC.
Reel/Frame 027241/0151 →
Assignment of Assignor's Interest Mar 29, 2012
From: RAO, DONALD
To: GRADALIS, INC.
Reel/Frame 027958/0466 →
Release Agreement Apr 25, 2012
From: THE TEXAS A&M UNIVERSITY SYSTEM
To: BURGESS, KEVIN
Reel/Frame 028108/0524 →
Assignment of Assignor's Interest May 22, 2012
From: RAO, DONALD; NEMUNAITIS, JOHN J.; SENZER, NEIL
To: GRADALIS, INC.
Reel/Frame 028251/0463 →
Corrective Assignment to Correct the Assignee's Address Previously Recorded on Reel 028108 Frame 0524. Assignor(S) Hereby Confirms the the Correct Address Is P.O. Box 13861, College Station, Tx 77841-3861. Jul 18, 2012
From: THE TEXAS A&M UNIVERSITY SYSTEM
To: BURGESS, KEVIN
Reel/Frame 028594/0519 →
Assignment of Assignor's Interest Aug 1, 2012
From: TEMPLETON, NANCY SMYTH; CHEN, LI
To: GRADALIS, INC.
Reel/Frame 028698/0290 →
Assignment of Assignor's Interest Nov 14, 2012
From: GRADALIS, INC.
To: BRUNICARDI, F. CHARLES
Reel/Frame 029295/0674 →
Assignment of Assignor's Interest Nov 30, 2012
From: BRUNICARDI, F. CHARLES
To: BAYLOR COLLEGE OF MEDICINE
Reel/Frame 029385/0753 →
Merger May 3, 2018
From: STRIKE BIO, INC.
To: GRADALIS, INC.
Reel/Frame 045709/0406 →
Patent Security Agreement Dec 20, 2019
From: GRADALIS, INC.
To: HC INNOVATIVE PARTNERS, LP, AS COLLATERAL AGENT
Reel/Frame 051396/0366 →